Brawn Biotech Stock

Brawn Biotech Net Margin

The Net Profit Margin of Brawn Biotech (530207.BO) as of Jul 26, 2026 is -12.92 %. In the previous year, Net Profit Margin was -7.56 % — a change of 70.94% (lower).

Net Margin

-12.92 %

YoY

70.94%

Last updated:

Net Profit Margin of Brawn Biotech is 2026 -12.92 % . Net Profit Margin of Brawn Biotech was 2025 -7.56 % . It decreases by 70.94% lower compared to the previous year.

For Brawn Biotech, the net margin of -12.9% is down versus -3.9% a few years ago.

Access this data via the Eulerpool API

Brawn Biotech Stock analysis

What does Brawn Biotech do? Brawn Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brawn Biotech stock

Net Profit Margin of Brawn Biotech is -12.92 % in 2026.

Access this data via the Eulerpool API

Margins — Brawn Biotech

All Key Metrics — Brawn Biotech